NASDAQ | ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.52% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 6.33% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.61% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.32% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 3.01% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.43% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.87% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.70% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 1.49% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.30% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.26% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.24% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.21% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.16% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.12% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.97% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 0.96% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 0.94% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 0.93% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 0.92% |